
Signed by: 

## Funmi Vanessa Ullam 

## **Signing request** 

15/02/2024, 17:28:19 

Created: 15/02/2024, 17:28:19 Description: Trustees Annual Report - 2022-2023 Document owner: Crescent Kids CIC Original document name: TAR report - 2022-2023 - Crescent Kids 1173388.pdf 

Original document checksum: 

1c5480d548da107c6c2055d938a5b34d2654fba66e8afe60adad070e965b662c (SHA256) 

## **Signee** 

Signed: 

16/02/2024, 12:56:17 

Comment: 

- 

Name as registered in practice management software: 

Ullam, Funmilayo 

Name as provided by signee: 

Funmi Vanessa Ullam 

E-mail address: 

vanessakesu@gmail.com 

IP Address: 

80.43.83.45 

Browser user agent: 

Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.0.0 Safari/537.36 

Powered by Client Engager. 17.4.0 / 16.1.0 

85 Great Portland Street First Floor London United Kingdom England and Wales W1W 7LT 

clients@rocksolidacc.com 02079657546 Company No. 13294278 



**To** 


## **Trustees' Annual Report for the period** 

Period start date Period end date 02 April 2022 01 April 2023 

**From** 

## Section A Reference and administration details 

**Charity name Other names charity is known by Registered charity number (if any)** 1173388 

## CRESCENT KIDS 

|**Charity's principal address**|5 Langley Park|5 Langley Park|
|---|---|---|
||London||
||||
||**Postcode**|NW7 2AA|



## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee(if any)**|
|---|---|---|---|---|
||Professor Alastair<br>Sutcliffe||||
||MaryAkinbiyi||||
||Tamsin Hunt||||
||Vanessa Ullam||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||**Names of the trustees for the charity, if any, (for example, any custodian trustees)**||||
||**Name**||**Dates acted if not for whole year**||
||||||
||||||



**TAR** 

March **2012** 

1 



## **Names and addresses of advisers (Optional information)** 

**Type of adviser Name Address** 

## **Name of chief executive or names of senior staff members (Optional information)** 

## **Section B** 

## **Structure, governance and management** 

## **Description of the charity’s trusts** 

- Type of governing document (eg. trust deed, constitution) 

How the charity is constituted 

CIO 

Association 

- (eg. trust, association, company) 

Appointment Trustee selection methods 

- (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C** 

## **Objectives and activities** 

**Summary of the objects of the charity set out in its governing document** 

1. Providing support, advice, education and information about sickle cell and thalassaemia. 

2. Providing information and raising awareness to gradually decrease the number of children born with sickle cell and thalassaemia 

3. Providing grants and funds towards studies to advance health and find a cure for Sickle Cell and thalassaemia. 

**TAR** 

March **2012** 

2 



Summary of Activities: 

1. Coordination and running of PPI sessions to ensure we capture the challenges and requirements from the friends and families of Paediatric sickle cell & Thalassaemia sufferers. 

2. Creation of useful content for parents and children affected by Sickle Cell. 

3. Fundraising activities 

4. Services launch 

**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

## **Additional details of objectives and activities (Optional information)** 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

**TAR** 

March **2012** 

3 



Achievements and performance 

## Section D 

## **Summary of the main achievements of the charity during the year** 

In 2023, we made a difference in the lives of 100’s of children with Sickle Cell Anaemia. 

We are proud to have undertaken impactful initiatives in both the UK and Nigeria, partnering closely with universities and hospitals to delve into research projects focused on understanding the lives of children living with sickle cell disease and their families. 

Through these partnerships, we have provided vital support, including essential supplements, food packages, clothing, and access to clean water. These efforts have directly benefited remarkable children living with sickle cell and have provided much-needed hope and support to communities in need. 

In the UK, particularly during the colder winter months, we have extended our support by providing free warm fleece duvet sets to eligible children with sickle cell, ensuring their comfort and well-being. 

Operationally, we have established a robust leadership team and are poised to expand our impact significantly in 2023 and beyond, amplifying our efforts to make a meaningful difference in the lives of those affected by sickle cell disease. 

We extend our heartfelt gratitude to all the donors, brands, volunteers, and friends who have stood by us on this mission, demonstrating unwavering support for these children and contributing to our collective efforts to alleviate their suffering. 


**TAR** 

March **2012** 

4 



## **Section E** 

## **Financial review** 

N/A there are currently no reserves. 

**Brief statement of the charity’s policy on reserves** 

**Details of any funds materially in deficit** 

N/A 

## **Further financial review details (Optional information)** 

You **may choose** to include additional information, where relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 

## **Section F** 

## **Other optional information** 

## **Section G Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s)** 

**Full name(s) Position (eg Secretary, Chair, etc)** 

**Date** 

**TAR** 

March **2012** 

5 




Signed by: 

## Funmi Vanessa Ullam 

## **Signing request** 

15/02/2024, 17:27:22 

Created: 15/02/2024, 17:27:22 Description: Trustees Annual Accounts - 2022-2023 Document owner: Crescent Kids CIC Original document name: CC16a - Trustees Annual Accounts - 2022-2023 - Crescent Kids 1173388.pdf Original document checksum: df8e7c3de3b3eb842cb511db29a5c119af2e582eedc56f2a8d7fc55b8606902b (SHA-256) 

## **Signee** 

Signed: 

16/02/2024, 13:02:23 

Comment: 

- 

Name as registered in practice management software: 

Ullam, Funmilayo 

Name as provided by signee: 

Funmi Vanessa Ullam 

E-mail address: 

vanessakesu@gmail.com 

IP Address: 

80.43.83.45 

Browser user agent: 

Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.0.0 Safari/537.36 

Powered by Client Engager. 17.4.0 / 16.1.0 

85 Great Portland Street First Floor London United Kingdom England and Wales W1W 7LT 

clients@rocksolidacc.com 02079657546 Company No. 13294278 




**Crescent Kids 1173388 Receipts and payments accounts CC16a For the period** 02/04/2022 01/04/2023 **To from** 

## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**1,962**<br>**143**<br>**1,510**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**3,614**<br>**-**<br>**-**<br>**-**<br>**3,614**<br>**151**<br>**302**<br>**1,181**<br> **1,634**<br>**-**<br>**-**<br> **-**<br>**1,634**<br>**1,981**<br>**-**<br>**-**<br>**1,981**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**1,962**<br>**143**<br>**1,510**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**3,614**<br>**-**<br>**-**<br>**-**<br>**3,614**<br>**151**<br>**302**<br>**1,181**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,634**<br>**-**<br>**-**<br>**-**<br>**1,634**<br> <br>**1,981**|**Total funds**<br>**to the nearest £**<br>**1,962**<br>**143**<br>**1,510**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**3,614**<br>**-**<br>**-**<br>**-**<br>**3,614**<br>**151**<br>**302**<br>**1,181**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,634**<br>**-**<br>**-**<br>**-**<br>**1,634**<br> <br>**1,981**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|
|Just Giving- Kogi State Fundraiser|**1,962**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**1,962**||**-**|
|CAF - CharityDonation from Citrix|**143**|||**143**||**-**|
|CAF - CharityDonation from VM Ware|**1,510**|||**1,510**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
|**_Sub total_**_(Gross income for AR)_|**3,614**|||**3,614**||**-**|
||||||||
|**A2 Asset and investment sales, (see**<br>**table).**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**||**-**|
|**_Sub total_**|**-**|||**-**||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
||||**-**|**3,614**||**-**|
||||||||
|Hostinger Website Hosting|**151**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**151**||**-**|
|Jasper.ai|**302**|||**302**||**-**|
|Vodafone|**1,181**|||**1,181**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|**_Sub total_ **|**1,634**|||**1,634**||**-**|
||||||||
|**A4 Asset and investment purchases,**<br>**(see table)**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**|||
|**_Sub total_ **|**-**|||**-**||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
||||**-**|**1,634**||**-**|
||||||||
||**1,981**|**-**|**-**|<br>**1,981**||**-**|
||**-**|**-**|**-**<br>**-**|**-**||**-**|
||**-**|**-**||**-**||**-**|
||**1,981**|**-**|**-**|**1,981**||**-**|



CCXX R1 accounts (SS) 

15/02/2024 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on behalf of all<br>the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the charity’s**<br>**own use**<br>**B1 Cash funds**|<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br> <br>Bank Account<br>**Details**<br>**Details**<br>**Details**<br>Signature|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**616**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**616**<br>**-**<br>Agreement Error<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||||
|||||



CCXX R2 accounts (SS) 

15/02/2024 

2 

